These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12970317)
21. Involvement of dysadherin and E-cadherin in the development of testicular tumours. Batistatou A; Scopa CD; Ravazoula P; Nakanishi Y; Peschos D; Agnantis NJ; Hirohashi S; Charalabopoulos KA Br J Cancer; 2005 Dec; 93(12):1382-7. PubMed ID: 16333245 [TBL] [Abstract][Full Text] [Related]
22. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702 [TBL] [Abstract][Full Text] [Related]
23. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390 [TBL] [Abstract][Full Text] [Related]
24. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923 [TBL] [Abstract][Full Text] [Related]
25. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene. Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940 [TBL] [Abstract][Full Text] [Related]
26. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. Shimamura T; Sakamoto M; Ino Y; Sato Y; Shimada K; Kosuge T; Sekihara H; Hirohashi S J Clin Oncol; 2003 Feb; 21(4):659-67. PubMed ID: 12586803 [TBL] [Abstract][Full Text] [Related]
27. The expression of CK19, vimentin and E-cadherin in differentiated thyroid carcinomas. Calangiu CM; Simionescu CE; Stepan AE; Cernea D; Zăvoi RE; Mărgăritescu C Rom J Morphol Embryol; 2014; 55(3):919-25. PubMed ID: 25329121 [TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. Furlan JC; Bedard YC; Rosen IB J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733 [TBL] [Abstract][Full Text] [Related]
29. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Lacroix L; Nocera M; Mian C; Caillou B; Virion A; Dupuy C; Filetti S; Bidart JM; Schlumberger M Thyroid; 2001 Nov; 11(11):1017-23. PubMed ID: 11762710 [TBL] [Abstract][Full Text] [Related]
30. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma. Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469 [TBL] [Abstract][Full Text] [Related]
32. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236 [TBL] [Abstract][Full Text] [Related]